Anne Marie Falk

Array ( [id] => 5875105 [patent_doc_number] => 20020049313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Method for introducing foreign material into higher eukaryotic cells' [patent_app_type] => new [patent_app_number] => 09/893637 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13895 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049313.pdf [firstpage_image] =>[orig_patent_app_number] => 09893637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032904 [patent_doc_number] => 20020019046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Direct differentiation of human pluripotent stem cells and characterization of differentiated cells' [patent_app_type] => new [patent_app_number] => 09/888309 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19089 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019046.pdf [firstpage_image] =>[orig_patent_app_number] => 09888309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6881051 [patent_doc_number] => 20010032339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1' [patent_app_type] => new [patent_app_number] => 09/884384 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10793 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20010032339.pdf [firstpage_image] =>[orig_patent_app_number] => 09884384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800806 [patent_doc_number] => 20020009431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Method for transplanting cells into the brain and therapeutic uses therefor' [patent_app_type] => new [patent_app_number] => 09/884431 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10787 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009431.pdf [firstpage_image] =>[orig_patent_app_number] => 09884431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967894 [patent_doc_number] => 20020090603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway' [patent_app_type] => new [patent_app_number] => 09/876187 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20166 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090603.pdf [firstpage_image] =>[orig_patent_app_number] => 09876187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814657 [patent_doc_number] => 20020039724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Neural progenitor cell populations' [patent_app_type] => new [patent_app_number] => 09/872183 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16253 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039724.pdf [firstpage_image] =>[orig_patent_app_number] => 09872183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402940 [patent_doc_number] => 20020037281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Methods of transducing neural cells using lentivirus vectors' [patent_app_type] => new [patent_app_number] => 09/866532 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14350 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037281.pdf [firstpage_image] =>[orig_patent_app_number] => 09866532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1136345 [patent_doc_number] => 06780409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Glutamic acid decarboxylase (GAD) based delivery system' [patent_app_type] => B2 [patent_app_number] => 09/863179 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 41 [patent_no_of_words] => 22743 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780409.pdf [firstpage_image] =>[orig_patent_app_number] => 09863179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801450 [patent_doc_number] => 20020009743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Neural progenitor cell populations' [patent_app_type] => new [patent_app_number] => 09/859351 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16187 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009743.pdf [firstpage_image] =>[orig_patent_app_number] => 09859351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6182046 [patent_doc_number] => 20020157127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Identification and purification of higher order transcription complexes from transgenic non-human animals' [patent_app_type] => new [patent_app_number] => 09/849243 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13262 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20020157127.pdf [firstpage_image] =>[orig_patent_app_number] => 09849243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1192832 [patent_doc_number] => 06730512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-04 [patent_title] => 'Combination immunogene therapy' [patent_app_type] => B2 [patent_app_number] => 09/826025 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 25197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730512.pdf [firstpage_image] =>[orig_patent_app_number] => 09826025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951388 [patent_doc_number] => 20020006661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Controlling gene expression in living cells' [patent_app_type] => new [patent_app_number] => 09/824358 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5517 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006661.pdf [firstpage_image] =>[orig_patent_app_number] => 09824358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710507 [patent_doc_number] => 07056738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Early stage multipotential stem cells in colonies of bone marrow stromal cells' [patent_app_type] => utility [patent_app_number] => 09/816182 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4608 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056738.pdf [firstpage_image] =>[orig_patent_app_number] => 09816182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999914 [patent_doc_number] => 20020028510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Human cord blood as a source of neural tissue for repair of the brain and spinal cord' [patent_app_type] => new [patent_app_number] => 09/801221 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26753 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028510.pdf [firstpage_image] =>[orig_patent_app_number] => 09801221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6741790 [patent_doc_number] => 20030159159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Human nerve growth factor exon 1 and exon 3 promoters' [patent_app_type] => new [patent_app_number] => 09/798883 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13856 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20030159159.pdf [firstpage_image] =>[orig_patent_app_number] => 09798883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638742 [patent_doc_number] => 20020016977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Method for production of a transgenic animal, and a transgenic animal produced by the method' [patent_app_type] => new [patent_app_number] => 09/790535 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5410 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016977.pdf [firstpage_image] =>[orig_patent_app_number] => 09790535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6552633 [patent_doc_number] => 20020111321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Human disease modeling using somatic gene transfer' [patent_app_type] => new [patent_app_number] => 09/780041 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6723 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111321.pdf [firstpage_image] =>[orig_patent_app_number] => 09780041 [rel_patent_id] =>[rel_patent_doc_number] =>)